BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16391518)

  • 1. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
    Yoon SH; Cho HI; Kim TG
    Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
    Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
    Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
    J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40-CD40 ligand interactions stimulate B cell antigen processing.
    Faassen AE; Dalke DP; Berton MT; Warren WD; Pierce SK
    Eur J Immunol; 1995 Dec; 25(12):3249-55. PubMed ID: 8566008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine model of CD40-activation of B cells.
    Liebig TM; Fiedler A; Klein-Gonzalez N; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
    J Vis Exp; 2010 Mar; (37):. PubMed ID: 20208476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
    Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
    J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking.
    Lahvis GP; Cerny J
    J Immunol; 1997 Aug; 159(4):1783-93. PubMed ID: 9257841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
    Baum D; Yaron R; Yellin MJ
    Cell Immunol; 1998 Nov; 190(1):12-22. PubMed ID: 9826442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
    Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
    Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal B cells fail to secrete interleukin-12.
    Guéry JC; Ria F; Galbiati F; Adorini L
    Eur J Immunol; 1997 Jul; 27(7):1632-9. PubMed ID: 9247571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.